Press & News

PathAI Recognized for the “Diagnostics Innovation of the Year” By BioTech Breakthrough

PathAI Ranked 420th Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

PathAI Announces Integrations with Leading AI-pathology companies Deep Bio, DoMore Diagnostics, Paige, and Visiopharm, through its AISight Image Management System

PathAI Launches PathExplore Fibrosis: An AI-Powered Pathology Breakthrough in Fibrosis, Collagen, and Fiber Quantification Directly from Whole Slide Images

VIZIA Diagnostics Selects PathAI and the AISight Image Management System to Support the Transition to Digital and AI-Powered Pathology

PathAI Unveils New Features on AISight® Image Management System: Introducing Guided Algorithm Review and Z-Stack Image Support

Clario and PathAI Collaborate to Deliver Integrated Solution for GI Clinical Trials

PathAI Announces Collaboration with the Crohn’s & Colitis Foundation to Advance Novel IBD Research and Development

PathAI Launches MET Predict on AISight to Enhance NSCLC Assessments

PathAI Collaborates with GoldPath to Elevate Digital Pathology Capabilities with AISight Image Management System

PathAI's AISight^Ⓡ Dx Image Management System is CE Marked for Primary Diagnosis

Quest Diagnostics Completes Acquisition of Select PathAI Diagnostics’ Lab Assets from PathAI, Accelerating Adoption of AI and Digital Pathology to Speed Cancer Diagnosis

PathAI to present AI-powered research insights at the European Association for the Study of the Liver Congress 2024

PathAI Expands Portfolio of AI-Powered Products, Announcing PathExplore^™ IOP and IHC Explore^™ Ahead of ASCO 2024

PathAI and Aster Insights Partner to Deliver Combined AI-Derived Structured Pathology and Multimodal Real-World Data Solutions

PathAI Announces Early Access Program to Drive Adoption of AISight Image Management System in Anatomic Pathology Laboratories Across Mainland Europe

PathAI Welcomes Mary Padilla, M.D., To Lead Clinical Development Services for Biopharma

PathAI announces PLUTO: a state-of-the-art Foundation Model to enhance AI-powered pathology tools

The Boston Globe Names Andy Beck to Tech Power Players 50

Quest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis; Forms Licensing Agreements with PathAI

Hoag Health System Selects PathAI and the AISight Image Management System to Support the Transition To Digital and AI-enabled Pathology

PathAI Partners with Google Cloud to Transform Drug Discovery and Precision Medicine Through AI-Powered Pathology

PathAI Announces Research Presentations at the 2024 AACR Annual Meeting

Quantum Pathology Enhances Digital Pathology Capabilities with the Adoption of PathAI's AISight Image Management System

PathAI Launches New Pathologist-Centric Features on AISight to Enable Efficient Case Review through Intelligent Case Prioritization and Real-Time Multi-Institutional Collaboration

PathAI Announces Exclusive Collaboration with Roche Tissue Diagnostics to Advance AI-enabled Interpretation for Companion Diagnostics

PathAI launches six additional oncology indications for PathExplore, an AI-powered pathology panel for spatial analysis of the tumor microenvironment

PathAI Commences New Year with Strong Foundation for Growth Following Key 2023 Achievements in AI-Powered Pathology Products, Strategic Partnerships, and Leadership Team Hires

PathAI Introduces TumorDetect, an AI Solution to Automate Tumor Assessment and Case Prioritization for Anatomic Pathology Labs

PathAI Announces Research Presentations at the San Antonio Breast Cancer Symposium

PathAI Launches ArtifactDetect Model on AISight, Pioneering Automated Slide Quality Analysis in Pathology Labs

PathAI Announces AISight Support of DICOM Standards and Commits to Being a Leader in Integrated Enterprise Image Architecture and Strategy

PathAI Announces Research Presentations at the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting

PathAI Announces New NASH/MASH Advisory Network to Guide Evidence Generation and Regulatory Strategy for Product Development

PathAI Announces Research Presentations at the Society for Immunotherapy of Cancer's 38th Annual Meeting

PathAI Diagnostics Unveils World's First AI-Assisted Laboratory Developed Test for MASLD and MASH

PathAI Announces Launch of AIM-TumorCellularity (AIM-TC), an AI-Based Tumor Cellularity Assessment Product, to Inform Advanced Molecular Testing

PathAI Announces Research Presentations at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

PathAI Announces Expansion of BioPharma Lab to Provide End-to-End Central Pathology and Histology Services

PathAI Launches AISight Link to Support Integration Solutions for Laboratory Customers and Biopharma Partners

FNIH and PathAI Forge Partnership to Advance Mucosal Healing in Ulcerative Colitis Research

PathAI Announces Commercial Availability of AISight Digital Pathology Image Management System to Power the Next Generation of Pathology Labs

PathAI Launches its AI-Powered PathExplore Data Access Program For Academic Researchers

PathAI Launches AIM-HER2 Breast Cancer, an Artificial Intelligence-Powered HER2 Scoring Algorithm for Biopharma Research and Clinical Labs

PathAI will Present on Analytical and Clinical Validation of AI-based NASH Clinical Trial Digital Pathology Tool at the European Association for the Study of the Liver Congress 2023, and Announces Launch of new NASH Explore Product

PathAI Announces New Executive Appointment to Drive Commercial Growth of Biopharma Partnerships, Lab Capabilities, and Clinical Innovation

PathAI Announces IBD Explore, an AI-powered Histopathology Panel to Unlock Insights for Ulcerative Colitis from the Inflammatory Microenvironment

PathAI and ConcertAI Partner to Create First-in-class Histopathology and Curated Clinical Real-World Data Product

Agilent and PathAI Partner to Deliver AI-Powered Assay Development Solutions for Biopharma Research and Clinical Applications

PathAI to Present on AI-based Models to Advance Tumor Analysis and Oncology Drug Development at American Association for Cancer Research Annual Meeting 2023

PathAI Announces PathExplore, an AI-powered Pathology Panel to Unlock Untapped Insights from the Tumor Microenvironment

PathAI Announces Collaboration with GSK on NASH Phase 2b Clinical Trial

PathAI Announces Early Adoption of its Digital Pathology Platform and Algorithms by Leading Anatomic Pathology Laboratories

PathAI Announces Two New Executives to Expand Regulatory Expertise and Precision Oncology Commercial Strategy

PathAI to Present on AI Models Supporting Advances in Oncology Research at Society for Immunotherapy of Cancer Annual Meeting

PathAI to Present Recent Advances in Applying AI-Powered Pathology Towards Liver Disease at the American Association for the Study of Liver Diseases (AASLD) 2022 Liver Meeting

PathAI Announces Extension of Multi-Year Collaboration Agreement with Bristol Myers Squibb

PathAI Receives Both FDA 510(k) Clearance and CE Mark for AISight Dx Platform

PathAI Research Shows Power of Artificial Intelligence to Predict Biomarkers from H&E Images

PathAI Appoints Brandon Eldredge as Chief Financial Officer

PathAI Appoints Elizabeth Storti as Chief People Officer

PathAI To Present Three Abstracts at International Liver Congress 2022

PathAI Announces Upcoming Presentations at the 2022 American Association for Cancer Research (AACR) Annual Meeting

PathAI and GlaxoSmithKline Sign Multi-Year Agreement to Accelerate Research and Drug Development

PathAI and Cleveland Clinic Announce Collaboration to Build Digital Pathology Infrastructure and Evolve Use of AI-Powered Pathology Algorithms in Research and Clinical Care

PathAI Announces Collaboration with Akoya Biosciences to Offer a Spatial Biology and AI-Powered Analysis Solution